CORONARY HEART DISEASE, FIBRINOGEN, AND PLASMA HEPARIN NEUTRALISING ACTIVITY
- 28 February 1981
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 317 (8218) , 495-496
- https://doi.org/10.1016/s0140-6736(81)91872-9
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- COMPUTERIZED TOMOGRAPHY OF THE ORBITSActa Ophthalmologica, 2009
- Free fatty acidemia as an inducer of systemic hyperfibrinogenemia and fibrinolytic inhibitionInflammation, 1981
- The effect of minor illness on the heparin thrombin clotting timeThrombosis Research, 1980
- Fatty acids, fibrinogen and blood flow: A general mechanism for hyperfibrinogenemia and its pathologic consequencesMedical Hypotheses, 1980
- HÆMOSTATIC FUNCTION AND CARDIOVASCULAR DEATH: EARLY RESULTS OF A PROSPECTIVE STUDYThe Lancet, 1980
- Relationship of plasma anti-heparin activity and platelet survival time in coronary diseaseAmerican Heart Journal, 1980
- Increased in vivo and in vitro platelet function in type II- and type IV-hyperlipoproteinemiaThrombosis Research, 1979
- A comparison between the plasma concentration of immunologically assayed platelet factor 4 and B-thromboglobulin and the heparin thrombin clotting timeThrombosis Research, 1979
- "EXHAUSTED" PLATELETS CONTINUE TO CIRCULATEThe Lancet, 1978
- THE SPECTRUM OF THYROID DISEASE IN A COMMUNITY: THE WHICKHAM SURVEYClinical Endocrinology, 1977